CIBC Private Wealth Group
EVH icon

CIBC Private Wealth Group’s Evolent Health EVH Stock Holding History

CIBC Private Wealth Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$400 Sell
100
-4,000
-98% -$22.2K ﹤0.01% 3088
2025
Q3 		$34.7K Buy
4,100
+4,000
+4,000% +$38.8K ﹤0.01% 1953
2025
Q2 		$1.13K Hold
100
– – ﹤0.01% 2756
2025
Q1 		$955 Sell
100
-5,800
-98% -$58.6K ﹤0.01% 2815
2024
Q4 		$74.3K Sell
5,900
-400
-6% -$7.03K ﹤0.01% 1524
2024
Q3 		$178K Buy
6,300
+100
+2% +$2.58K ﹤0.01% 1240
2024
Q2 		$121K Sell
6,200
-235
-4% -$6K ﹤0.01% 1324
2024
Q1 		$205K Sell
6,435
-700
-10% -$22.3K ﹤0.01% 1105
2023
Q4 		$236K Buy
+7,135
New +$202K ﹤0.01% 1012
2023
Q3 		– Sell
-7,135
Closed -$216K – 1095
2023
Q2 		$216K Hold
7,135
– – ﹤0.01% 822
2023
Q1 		$232K Buy
7,135
+435
+6% +$13.8K ﹤0.01% 819
2022
Q4 		$401K Hold
6,700
– – ﹤0.01% 648
2022
Q3 		$241K Hold
6,700
– – ﹤0.01% 826
2022
Q2 		$206K Hold
6,700
– – ﹤0.01% 878
2022
Q1 		$216K Buy
+6,700
New +$175K ﹤0.01% 940
2018
Q1 		– Sell
-35
Closed – – 1979
2017
Q4 		$0 Buy
+35
New +$493 ﹤0.01% 1941

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIBC Private Wealth Group's EVH Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Evolent Health (EVH) stake by 98% in Q4 2025, selling an estimated $22.2K and leaving 100 shares worth $400. The position accounts for ﹤0.01% of the portfolio, ranked #3088.

CIBC Private Wealth Group first reported a position in EVH in Q4 2017 and has held it in 16 quarters since. The position peaked at $401K in Q4 2022. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • CIBC Private Wealth Group held 100 shares of Evolent Health worth $400 as of Q4 2025.
  • CIBC Private Wealth Group sold 4,000 Evolent Health shares in Q4 2025, an estimated $22.2K.
  • Evolent Health made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3088 holding.
  • CIBC Private Wealth Group first reported a position in Evolent Health in Q4 2017 and has held it in 16 quarters since.
  • CIBC Private Wealth Group's Evolent Health position peaked at $401K in Q4 2022.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.